KardiaMobile for detecting atrial fibrillation

pulse. If an irregular pulse is then detected, a 12-lead ECG is done. If an irregular pulse is undetected by a 12-lead ECG recording then an ambulatory monitor, event record or other ECG technology should be done whether or not the person has symptoms. Costs 2.6 The cost of a single-lead KardiaMobile device is £82.50 (excluding VAT) The Kardia app is free of cost. For more details, see the website for KardiaMobile. 3 Evidence Clinical evidence The main clinical evidence comprises 27 studies including 5 randomised controlled trials 3.1 There were 27 studies relevant to the decision problem in the scope: • 5 randomised controlled trials (RCTs) • 7 diagnostic accuracy studies • 1 case-control study • 13 single-arm observational studies • 1 case report. 3.2 Of the 27 included studies, 16 studies were peer reviewed, including 4 UK studies (Bray et al. 2021, Dimarco et al. 2018, Reed et al. 2021, Reed et al. 2019), one of which is an RCT (Reed et al. 2019). The included studies covered 6 population groups: • people with palpitations • people with a history of atrial fibrillation (AF), who have had treatment (ablation, cardioversion, or medical therapy) to restore sinus rhythm and
